Wound Care Biologics Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, China, India, Japan, Brazil, Mexico, South Africa, Saudi Arabia), Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2018 – 2024

Report ID: GMI2925

  Table of Contents Inquiry Before Buying
Summary Methodology Request for Customization

Wound Care Biologics Market size is projected to experience significant growth from 2018 to 2024.

Rising elderly patient pool across the globe along with increasing prevalence of diabetes will act as major growth rendering factors for wound care biologics market growth. Globally, the around 415 million people were living with diabetes as of 2015 and the number is expected to reach 642 million by 2040 as per International Diabetes Federation (IDF). Age increases the risk of developing chronic diseases such as diabetes making the geriatric population more susceptible to chronic wounds. Furthermore, diabetes leads to complications such as ulcers in the lower extremity which are leading cause of disability and premature death. Such factors will propel demand for wound care biologics in the future.

Increasing incidences of burn injuries is another significant growth impacting factor for wound care biologics market. Burns are the leading cause of injuries accounting for 5-12% of all the injuries occurring across the globe. Rising mortality associated with burn injuries will further increase demand for wound care biologics in the coming years. For instance, as per WHO, around 2,65,000 deaths occur due to burn injuries every year. Also, burn injuries pose a huge economic burden on the healthcare systems. Furthermore, rapid technological advancements for wound care management such as development of scaffolds, skin substitutes and bio-membranes will drive business market growth.

Favorable government initiatives for increasing awareness and stimulating adoption of wound care biologics will augment industry growth. For instance, ‘Heal Not Hurt’ campaign organized by wound care specialists along with Mölnlycke Health Care to spread awareness about pain and trauma associated with wounds.  Also, The Wound Care Center at Canyon Vista Medical Center aims to raise awareness about diabetic foot ulcers among patients suffering from diabetes through National Diabetes Campaign. All such factors will spur demand for wound care biologics over the forecast timeline. However, high cost of wound care biologics resulting in unaffordability for patients in the developing countries would impede market growth.

Biological skin substitutes accounted for largest market share owing to increasing adoption of technology advanced tissue-engineered products to treat non-healing ulcers including diabetic foot ulcers and pressure ulcers. The biological skin substitutes are further segmented into acellular derived products, human donor derived products and biosynthetic products. Advantages offered by these skin substitutes such as reduced wound healing time, post-operative contracture, temporary or permanent wound closure will augment its demand over the coming years.

Based on the wound type, ulcers business segment dominated the wound care biologics market. Increasing prevalence of diabetes resulting into complications such as ulceration in the foot coupled with higher incidences of pressure ulcers among the geriatric patient pool will spur demand for biologics for effective wound care management and drive ulcers segment market growth. Rising incidences of burn injuries along with increasing traumatic events such as fire accidents will boost burns segment growth over the coming years.

The various end-users of the wound care biologics include hospitals, ambulatory surgical centers, burn centers and wound clinics. Increasing usage of wound care biologics in the hospital settings for the treatment of ulcers, burns and accidents causing chronic wounds will propel hospitals segment market size.

U.S. wound care biologics market accounted for majority of the share owing to increasing incidences of burn injuries in the country. As per American Burn Association, more than 60% of the acute hospitalizations occur due to burn injuries. Also, around 200 patients are admitted per year in burn centers in the U.S. for effective treatment of burn injuries and skin disorders.  Moreover, higher incidences of diabetic complications, presence of major industry players along with availability of wound care biologics in the country will boost overall North America industry growth.  

Asia Pacific wound care biologics market will grow at a rapid pace over the forecast period. Higher incidences of burn injuries in the Asian countries will drive regional industry growth. For instance, according to WHO, more than 96% of the fatal fire-related burns occurs in low- and middle-income countries. Moreover, presence of huge diabetic and geriatric population in the developing countries such as China and India will boost drive Asia Pacific wound care biologics market growth.

Some of the key industry players operating in the global wound care biologics market include Mölnlycke Health Care, Smith & Nephew, Integra Lifesciences, Mimedx Group, Organogenesis, Wright Medical, Osiris Therapeutics, Vericel, Derma Sciences, Kerecis, Amnio Technology, Solsys Medical, Acell, Marine Polymer Technologies and Skye Biologics. The market players focus on research and development activities to develop novel products for effective treatment of chronic wounds.

Wound Care Biologics Market By Product, 2013-2024 (USD Million)

  • Biological skin substitutes
    • Human donor tissue-derived products
    • Acellular animal-derived products
    • Biosynthetic products
  • Topical agents

Wound Care Biologics Market By Wound Type, 2013-2024 (USD Million)

  • Ulcers
    • Diabetic Foot Ulcers
    • Pressure Ulcers
    • Venous Ulcers
    • Others
  • Burns
  • Surgical & traumatic wounds

Wound Care Biologics Market By End-use, 2013-2024 (USD Million)

  • Hospitals
  • Ambulatory surgical centers
  • Burn centers & wound clinics

The above information is provided for the following regions and countries:

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Asia Pacific
  • Japan
  • China
  • India
  • Latin America
  • Brazil
  • Mexico
  • Middle East and Africa
  • South Africa
  • Saudi Arabia

Company Profiles

  • Smith & Nephew
  • Integra Lifesciences
  • Mölnlycke Health Care AB
  • Mimedx Group
  • Organogenesis
  • Wright Medical
  • Osiris Therapeutics
  • Vericel
  • Derma Sciences
  • Kerecis
  • Amnio Technology
  • Solsys Medical
  • Acell
  • Skye Biologics
  • Marine Polymer Technologies



What Information does this report contain?

Historical data coverage: 2013 to 2017; Growth Projections: 2018 to 2024.
Expert analysis: industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
6-7 year performance forecasts: major segments covering applications, top products and geographies.
Competitive landscape reporting: market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.

Request for Customization

Our Market Research Reports Include:

  • Market snapshot
  • Market Segmentation
  • Value Chain Analysis
  • Growth Dynamics
  • Potential Market Opportunities
  • Regulatory Overview
  • Technology Evolution
  • Innovation & Sustainability

Why Global Market Insights?

 Comprehensive Research
  • All-inclusive coverage
  • In-depth and granular data (ex: information for 8 to 15 countries, with clients open to add to this list, in each report)
  • Penetrative insights & latest trends
  • Offers holistic understanding of the market
 Data Accuracy & Reliability
  • Unique methodology
  • Iterative in nature to eliminate errors
  • Detailed methodology, scope, assumptions and data sources available for reference
 Post-Sales Support
  • Committed to making a positive difference for our clients
  • Given the nature of this industry, we are committed to ensure that our clients get maximum return on their investment in our services
  • Every purchase comes with an option to obtain additional information:
    • up to 10% of the original cost
    • 45-minute analyst tele-call to obtain further clarity on the market.
 Security & Confidentiality
  • Global Market Insights, Inc. strictly adheres to PCI-DSS security norms.
  • Only PCI-DSS compliant payment methods used for highest level of client data security
This site is protected by Trustwave's Trusted Commerce program Authorize.Net Merchant - Click to Verify

Connect with our sales team

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info. I Agree